|SEQ_NO||1||Date of announcement||2022/10/11||Time of announcement||14:19:19|
|Subject||Announcement of TTY Biopharm's unaudited income information in September 2022|
|Date of events||2022/10/11||To which item it meets||paragraph 53|
|Statement||1.Date of occurrence of the event:2022/10/11
2.Company name:TTY Biopharm Co., Ltd.
3.Relationship to the Company (please enter ”head office” or ”subsidiaries”):Head office
4.Reciprocal shareholding ratios:N/A
5.Cause of occurrence:TTY Biopharm posted a consolidated net sales of $531,569 thousands (expressed in NT dollars; unaudited), a consolidated operating profit of $171,347 thousands, and a consolidated income before tax of $209,202 thousands in September 2022; net income attributed to stockholders of the company was $159,955 thousands; EPS is $0.64.
Year-to-date consolidated net sales was $3,528,806 thousands (in NT dollars; unaudited), a consolidated operating profit was $913,306 thousands and consolidated income before tax was $1,081,058 thousands until September 2022; year-to-date net income attributed to stockholders of the company was $855,521 thousands; EPS is $3.44.
7.Any other matters that need to be specified:
The numbers above are unaudited. In term of the final net sales and profits, quarterly financial reports audited by independent accountants will prevail.